Literature DB >> 9423717

Longitudinal comparison of dialysis access methods: risk factors for failure.

T C Hodges1, M F Fillinger, R M Zwolak, D B Walsh, F Bech, J L Cronenwett.   

Abstract

PURPOSE: To compare dialysis access patency rates and identify risk factors for failure.
METHODS: All access procedures at our institution from 1987 to 1996 were reviewed. Primary procedures were surgically implanted dual-lumen central venous hemodialysis catheters (SIHCs), peritoneal dialysis catheters (PDCs), arteriovenous fistulas (AVFs), and prosthetic shunts (PTFEs).
RESULTS: Five hundred eighty-five primary procedures (236 PTFEs, 87 AVFs, 112 SIHCs, and 150 PDCs) and 259 secondary procedures (215 PTFEs, 14 AVFs, 0 SIHCs, and 30 PDCs) were performed on 350 patients. By life table analysis, SIHCs exhibited the lowest primary patency rate (9% at 1 year; p < 0.0001), whereas PDCs had the highest primary patency rate (57% at 1 year; p < 0.02). The primary patency rates of AVFs and PTFEs was similar, with 43% and 41% 1-year patency rates, respectively (p = 0.70). Less-stringent reporting methods would have increased apparent 1-year patency rates by 9% to 41%. With regard to secondary patency, there was no significant difference between PTFEs and PDCs, with 1-year patency rates of 59% and 70%, respectively (p = 0.62), but PTFEs were more frequently revised. In addition, there was no significant difference between AVF and PTFE secondary patency rates, with 1-year patency rates of 46% and 59%, respectively. Early differences in patency rates for AVFs, PTFEs, and PDCs diminished over time, and at 4 years AVFs had the best secondary patency rate (p = 0.6). The most common reasons for access failure were: PTFEs, thrombosis; AVFs, thrombosis and failure to mature; SIHCs, inadequate dialysis; PDCs, infection and inadequate exchange. By regression analysis, a history of a previous unsalvageable PTFE was the only significant risk factor for failure of a subsequent PTFE (p < 0.01), and the risk of graft failure increased exponentially with the number of previous PTFE shunts. Diabetes was the only significant risk factor for failure of PDCs (p < 0.02; odds ratio, 2.0).
CONCLUSIONS: The patency rate for PTFEs is similar to that for AVFs, but AVFs require fewer revisions. When replacing a failed access graft, the risk of PTFE failure increases with the number of prior unsalvageable PTFE shunts. PDCs have excellent patency rates, but failure rates are doubled in patients with diabetes. Because of poor patency rates and inadequate dialysis flow rates, SIHCs should be avoided when possible. Reporting methods dramatically affect apparent patency rates, and reporting standards are needed to allow meaningful comparisons in the dialysis access literature.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9423717     DOI: 10.1016/s0741-5214(97)70014-4

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  28 in total

1.  Patency and life-spans of failing hemodialysis grafts in patients undergoing repeated percutaneous de-clotting.

Authors:  A V Mansilla; B D Toombs; W K Vaughn; J I Zeledon
Journal:  Tex Heart Inst J       Date:  2001

2.  Clinical analysis of hemodialysis vascular access: comparision of autogenous arterioveonus fistula & arteriovenous prosthetic graft.

Authors:  Duk-Sil Kim; Sung-Wan Kim; Jun-Chul Kim; Ji-Hyung Cho; Joon-Hyuk Kong; Chang-Ryul Park
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2011-02-12

3.  Computerised analysis of auscultatory sounds associated with vascular patency of haemodialysis access.

Authors:  H A Mansy; S J Hoxie; N H Patel; R H Sandler
Journal:  Med Biol Eng Comput       Date:  2005-01       Impact factor: 2.602

4.  An alternative vascular access technique for haemodialysis; the loop mid-thigh graft.

Authors:  A Bagul; M Kaushik; M D Kay; M L Nicholson
Journal:  Ann R Coll Surg Engl       Date:  2006-09       Impact factor: 1.891

5.  Long-term outcome of a cuffed expanded PTFE graft for hemodialysis vascular access.

Authors:  George Tsoulfas; Martin Hertl; Dicken S C Ko; Nahel Elias; Francis L Delmonico; Linda Romano; Isabel Fernandes; David Schoenfeld; Tatsuo Kawai
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

6.  Adipose phenotype predicts early human autogenous arteriovenous hemodialysis remodeling.

Authors:  Christine R Mauro; Kui Ding; Hui Xue; Ming Tao; Alban Longchamp; Michael Belkin; Bruce S Kristal; C Keith Ozaki
Journal:  J Vasc Surg       Date:  2014-09-26       Impact factor: 4.268

Review 7.  Definitions and End Points for Interventional Studies for Arteriovenous Dialysis Access.

Authors:  Gerald A Beathard; Charmaine E Lok; Marc H Glickman; Ahmed A Al-Jaishi; Donna Bednarski; David L Cull; Jeffery H Lawson; Timmy C Lee; Vandana D Niyyar; Donna Syracuse; Scott O Trerotola; Prabir Roy-Chaudhury; Surendra Shenoy; Margo Underwood; Haimanot Wasse; Karen Woo; Theodore H Yuo; Thomas S Huber
Journal:  Clin J Am Soc Nephrol       Date:  2017-07-20       Impact factor: 8.237

8.  Risk factors associated with inadequate veins for placement of arteriovenous fistulas for hemodialysis.

Authors:  Yuichi Sato; Masahito Miyamoto; Shina Sueki; Tsutomu Sakurada; Kenjiro Kimura; Ryuto Nakazawa; Maki Yoshioka; Hideo Sasaki; Satetsu Miyano; Tatsuya Chikaraishi
Journal:  J Artif Organs       Date:  2013-09-11       Impact factor: 1.731

Review 9.  Challenges and novel therapies for vascular access in haemodialysis.

Authors:  Jeffrey H Lawson; Laura E Niklason; Prabir Roy-Chaudhury
Journal:  Nat Rev Nephrol       Date:  2020-08-24       Impact factor: 28.314

10.  Outcomes of two different polytetrafluoroethylene graft sizes in patients undergoing maintenance hemodialysis.

Authors:  R Afshar; S Sanavi; S Afshin-Majd; A Davati
Journal:  Indian J Nephrol       Date:  2009-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.